Article Text

Download PDFPDF
Comprehensive evaluation of clinical pharmacists' interventions in a large Austrian tertiary care hospital
  1. Gunar Stemer1,
  2. Gerda Laml-Wallner1,
  3. Ingrid Kuegler1,
  4. Petra Poelzleitner1,
  5. Simone Messner1,
  6. Sonja Steininger1,
  7. Elfriede Dolinar1,
  8. Sonja Zehetmayer2
  1. 1Department of Pharmacy, Vienna General Hospital - Medical University Campus, Vienna, Austria
  2. 2Department of Medical Statistics, Medical University Vienna, Vienna, Austria
  1. Correspondence to  Dr Gunar Stemer,Department of Pharmacy, Vienna General Hospital - Medical University Campus, Währinger Gürtel 18-20, Vienna 1090, Austria; gunar.stemer{at}

Objectives To analyse drug-related problems (DRPs) and describe clinical pharmacists' interventions

Method A prospective 22-week observational descriptive clinical pharmacists' intervention study on six different wards of an Austrian tertiary care university hospital. In-depth analysis of DRPs, performed interventions and inter-rater and intra-rater variability analysis of interventions' significance assessment was conducted. Type and frequency of DRPs, clinical pharmacists' interventions and the physicians' acceptance rate were recorded. Further outcome parameters were the clinical significance of the interventions and the proportion of those with a cost-reducing potential.

Results A total of 478 DRPs were detected during 138 ward rounds. The most common DRPs related to specific therapy discussions (30.1%), organisational advice (14.2%), medical chart errors (7.7%), untreated indications (7.5%) and drug use without indication (6.9%). Clinical pharmacists provided information (42.9%), suggested the addition of new drugs (13.4%) and the adaptation of drug dosages (12.6%). Antibacterials for systemic use, antithrombotics and drugs for acid-related disorders were commonly implicated. The mean acceptance rate of interventions was 54.7%. Three out of four clinical pharmacists' interventions were rated to be significant. The inter-rater reliability analysis of clinical significance immediately and 2 weeks after study completion showed a fair to moderate agreement (Fleiss's κ 0.35, pairwise Spearman correlation coefficients between 0.5 and 0.74, all p < 0.0001). One out of 20 interventions showed a cost-reducing potential.

Conclusions The results highlight a positive impact of clinical pharmacy services in a continually developing environment. Although, on average, every second intervention was immediately accepted, the proportion of significant interventions was high. Clinical pharmacy services are one method of addressing evident DRPs in hospitalised patients in Austria.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.